ATF5 and chronic myelogenous leukemia, BCR-ABL1 positive: First, it was observed that neither siRNA-mediated ATF5 depletion nor engineered disruption of the ATF5 gene affected the survival of HAP1 chronic myelogenous leukemia cell lines.